Newly recognized cutaneous drug eruptions

被引：4

作者：

Callen, Jeffrey P. ^{[1
]}

机构：

[1] Univ Louisville, Sch Med, Div Dermatol, Louisville, KY 40292 USA

来源：

DERMATOLOGIC CLINICS | 2007年 / 25卷 / 02期

关键词：

D O I：

10.1016/j.det.2007.01.003

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Many new drugs are entering the marketplace and although some cutaneous reactions might be noted in the preclinical evaluation, some of the reactions, particularly those that are rare, will not be noted until the drugs enter widespread use. In addition, distinctive reactions may occur, as is the case with epidermal growth factor-receptor inhibitors. Careful observation and evaluation might result in a better understanding of "naturally" occurring skin disease.

引用

页码：255 / +

页数：8

共 37 条

[1] Dermatologic side effects associated with the epidermal growth factor receptor inhibitors [J].

Agero, Anna Liza C. ;

Dusza, Stephen W. ;

Benvenuto-Andrade, Cristiane ;

Busam, Klaus J. ;

Myskowski, Patricia ;

Halpern, Allan C. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 55 (04) :657-670

[2] Toxic epidermal Necrolysis associated with high intake of sildenafil and its response to infliximab [J].

Al-Shouli, S ;

Abouchala, N ;

Bogusz, MJ ;

Al Tufail, M ;

Thestrup-Pedersen, K .

ACTA DERMATO-VENEREOLOGICA, 2005, 85 (06) :534-535

[3] A case of lichenoid drug eruption associated with sildenafil citratus [J].

Antiga, E ;

Melani, L ;

Cardinali, C ;

Giomi, B ;

Caproni, M ;

Francalanci, S ;

Fabbri, P .

JOURNAL OF DERMATOLOGY, 2005, 32 (12) :972-975

[4] Panniculitis during dasatinib therapy for imatinib-resistant chronic myelogenous leukemia [J].

Assouline, Sarit ;

Laneuville, Pierre ;

Gambacorti-Passerini, Carlo .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (24) :2623-2624

[5] Imatinib-induced sweet syndrome in a patient with chronic myeloid leukemia [J].

Ayirookuzhi, SJ ;

Ramshesh, P ;

Mills, G .

ARCHIVES OF DERMATOLOGY, 2005, 141 (03) :368-370

[6] Etanercept-induced subacute cutaneous lupus erythematosus [J].

Bleumink, GS ;

ter Borg, EJ ;

Ramselaar, CG ;

Stricker, BHC .

RHEUMATOLOGY, 2001, 40 (11) :1317-1319

[7] Eosinophilic cellulitis (Wells' syndrome) as a cutaneous reaction to the administration of adalimumab [J].

Boura, P. ;

Sarantopoulos, A. ;

Lefaki, I. ;

Skendros, P. ;

Papadopoulos, P. .

ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (06) :839-840

[8] Pityriasis rosea-like eruption during treatment with imatinib mesylate: Description of 3 cases [J].

Brazzelli, V ;

Prestinari, F ;

Roveda, E ;

Barbagallo, T ;

Bellani, E ;

Vassallo, C ;

Orlandi, E ;

Passamonti, F ;

Borroni, G .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 53 (05) :S240-S243

[9]

Burgin Susan, 2005, Adv Dermatol, V21, P279, DOI 10.1016/j.yadr.2005.03.002

[10] How frequently are drugs associated with the development or exacerbation of subacute cutaneous lupus? [J].

Callen, JP .

ARCHIVES OF DERMATOLOGY, 2003, 139 (01) :89-90

← 1 2 3 4 →